NEW YORK, April 23, 2019 – Levi & Korsinsky announces the commencement of a class action on behalf of AVEO Pharmaceuticals, Inc. (“AVEO Pharmaceuticals”) (NASDAQ: AVEO) shareholders who purchased shares between August 4, 2016 and January 31, 2019. You are hereby notified that the AVEO class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To get more information about the AVEO Pharmaceuticals lawsuit go to: https://www.zlk.com/pslra-1/aveo-pharmaceuticals-inc-loss-form or contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The AVEO class action complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the TIVO‑3 trial was inadequately designed to address the OS concerns regarding AVEO’s lead candidate drug, tivozanib, from the TIVO-1 trial presented in June 2013; (ii) tivozanib had insufficient survival data to meet FDA approval following its initial 2013 rejection; (iii) this lack of sufficient survival data would put tivozanib at greater risk of delayed FDA approval; and (iv) as a result, AVEO’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in AVEO Pharmaceuticals you have until April 26, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171